Introduction
This document serves as a formal corrigendum for the research article titled "CircMIB1 inhibits glioma development and progression through a competing endogenous RNA interaction network," originally published in Frontiers in Molecular Biosciences in 2024. The original study explored the regulatory role of the circular RNA CircMIB1 in glioma, a highly aggressive brain tumor. While the scientific data and conclusions regarding the CircMIB1/miR-1290 axis remain valid, several administrative and attribution errors required correction to ensure the integrity of the academic record.
Administrative and Attribution Corrections
The primary purpose of this corrigendum is to rectify clerical errors related to authorship, institutional affiliation, and funding sources.
Authorship and Contributions
The original publication contained errors in the author list and the designation of the corresponding author. The corrected author list is: Simin Chen, Longping Li, Wei Xu, Nanjiao Xie, Huiting Xu, Yongjun Zhou, Ying Zou, Kai Yi, and Zuping Zhang.
Crucially, Zuping Zhang has been reinstated as the primary corresponding author. The "Author Contributions" section has also been updated to accurately reflect the division of labor:
- SC: Conceptualization, Data curation, Formal Analysis, Investigation, Methodology, Software, Writing–original draft.
- LL, WX: Methodology, Software.
- NX, HX, YZ, YZ, KY: Data curation, Formal Analysis.
- ZZ: Conceptualization, Funding acquisition, Project administration, Resources, Supervision, Writing–review and editing.
Institutional Affiliation
An error in the institutional affiliation of the researchers was identified. The affiliation previously listed as being part of Sichuan University has been corrected to the School of Xiangya Basic Medical Science, Central South University, Changsha, Hunan, China. This correction is vital for institutional credit and accurate bibliometric tracking.
Funding Statement
The original article failed to properly credit the funding body. The research was supported by the Hunan Provincial Natural Science Foundation of China (No. 2024JJ9575).
Scientific Integrity
The authors emphasize that these administrative updates do not alter the scientific findings or conclusions of the original study. The investigation into how CircMIB1 acts as a molecular brake on glioma progression through a competing endogenous RNA (ceRNA) network remains scientifically sound and unchanged.
Conclusion
Maintaining an accurate scientific record is essential for transparency and accountability in research. This corrigendum ensures that the contributors and supporting institutions are correctly recognized, providing a reliable foundation for future citations and research into glioma therapies.
Summary updated